Scripps Health has appointed several new staff members to the Scripps Genomics Medicine Program, an initiative it announced last fall. San Diego’s North County Times reported last week that the program has just begun hiring and that appointees include Nicholas Schork, director of research; Kelly Frazer, director of genomic biology, and Sarah Shaw Murray, director of genetics. Schork is a professor of psychiatry at the University of California, San Diego. Frazer joins Scripps from Perlegen Sciences, where she served as vice president of genomics, and Shaw Murray was formerly a staff geneticist at Illumina.
Eric Topol, the former chief of academic and cardiovascular medicine at the Cleveland Clinic, was hired last fall to lead the Scripps genomics program.
Sue Siegel, formerly president emeritus of Affymetrix, has been named a partner at the Silicon Valley venture-capital firm Mohr Davidow Ventures.
Affymetrix disclosed that Siegel had resigned as president emeritus last week [In Sequence 03-27-07].
MDV said that Siegel will help the company “invest in cross-discipline companies” involved in clinical and medical technological development.
Michael Christman has been appointed as president and CEO of the Coriell Institute for Medical Research, effective June 1. Christman will supervise the scientific and management operations at Coriell, and will also lead “a new initiative to identify human genetic variation that contributes to diseases such as cancer, heart disease, and obesity,” the institute said in a statement.
Christman most recently was as professor and founding chair of the department of genetics and genomics at the Boston University School of Medicine.
Alan Winter is among the recipients of the 2007 British Columbia Biotechnology Awards, presented annually by LifeSciences British Columbia “to recognize individuals and organizations that have made outstanding contributions to the development of British Columbia's biotechnology industry, and to increase public awareness and understanding of life sciences in the province.”
Winter is president and CEO of Genome British Columbia, a position he has held since January 2002.